{"name": "Achillion Pharmaceuticals",
 "permalink": "achillion-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/achillion-pharmaceuticals",
 "homepage_url": "http://www.achillion.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "AchillionPharma",
 "category_code": "biotech",
 "number_of_employees": 200,
 "founded_year": 1998,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@achillion.com",
 "phone_number": "203-624-7000",
 "description": "biotechnology company",
 "created_at": "Sat Sep 26 06:28:29 UTC 2009",
 "updated_at": "Tue Apr 02 04:49:13 UTC 2013",
 "overview": "\u003Cp\u003EAchillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. It focuses on the development of antivirals for the treatment of HIV infection and chronic hepatitis C; and antibacterials for the treatment of serious hospital-based bacterial infections. \u003C/p\u003E\n\n\u003Cp\u003EThe company\u00e2\u20ac\u2122s lead drug candidate is elvucitabine, an antiviral in phase II clinical trials for the treatment of HIV infection. It also develops ACH-702, a preclinical candidate for the treatment of serious hospital-based bacterial infection; and NS4A Antagonists, a preclinical-stage program for chronic hepatitis C. The company has research collaboration with Gilead Sciences, Inc. to develop and commercialize compounds for the treatment of chronic hepatitis C. \u003C/p\u003E\n\n\u003Cp\u003EAchillion was founded in 1998 and is based in New Haven, Connecticut.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       34],
      "assets/images/resized/0006/0871/60871v2-max-150x150.png"],
     [[250,
       56],
      "assets/images/resized/0006/0871/60871v2-max-250x250.png"],
     [[303,
       69],
      "assets/images/resized/0006/0871/60871v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Michael",
      "last_name": "D. Kishbauch",
      "permalink": "michael-d-kishbauch",
      "image": null}},
   {"is_past": false,
    "title": "Executive Vice President of Research \u0026 Chief Scientific Officer",
    "person":
     {"first_name": "Milind",
      "last_name": "S. Deshpande",
      "permalink": "milind-s-deshpande",
      "image": null}},
   {"is_past": false,
    "title": "Vice President \u0026 CFO",
    "person":
     {"first_name": "Mary",
      "last_name": "Kay Fenton",
      "permalink": "mary-kay-fenton",
      "image": null}},
   {"is_past": false,
    "title": "Board Director",
    "person":
     {"first_name": "Kurt",
      "last_name": "Graves",
      "permalink": "kurt-graves",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$50.1M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://ir.achillion.com/releasedetail.cfm?ReleaseID=500371",
    "source_description": "Achillion Announces Private Placement of $50 Million",
    "raised_amount": 50100000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 8,
    "funded_day": 18,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Pappas Ventures",
         "permalink": "pappas-ventures",
         "image":
          {"available_sizes":
            [[[150,
               131],
              "assets/images/resized/0004/9245/49245v1-max-150x150.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-250x250.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quaker BioVentures",
         "permalink": "quaker-bioventures",
         "image":
          {"available_sizes":
            [[[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-150x150.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-250x250.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clarus Ventures",
         "permalink": "clarus-ventures",
         "image":
          {"available_sizes":
            [[[150,
               82],
              "assets/images/resized/0005/0042/50042v2-max-150x150.png"],
             [[250,
               137],
              "assets/images/resized/0005/0042/50042v2-max-250x250.png"],
             [[308,
               169],
              "assets/images/resized/0005/0042/50042v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "300 George Street",
    "address2": "",
    "zip_code": "06511",
    "city": "New Haven",
    "state_code": "CT",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Achillion to Raise $41.8 Million Through Registered Direct Offering",
    "stoned_year": 2012,
    "stoned_month": 8,
    "stoned_day": 30,
    "source_url": "http://finance.yahoo.com/news/achillion-raise-41-8-million-223000968.html",
    "source_text": "",
    "source_description": "Achillion to Raise $41.8 Million Through Registered Direct Offering",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Achillion Pharmaceuticals",
      "permalink": "achillion-pharmaceuticals"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:ACHN"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        120],
       "assets/images/resized/0006/0872/60872v1-max-150x150.jpg"],
      [[250,
        201],
       "assets/images/resized/0006/0872/60872v1-max-250x250.jpg"],
      [[450,
        362],
       "assets/images/resized/0006/0872/60872v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}